GBSPP LIMITEDActive

Company number 10385691Private limited companyIncorporated 2016

Key figures

£94,207+136.0%
Net assets 2024/25
+46.8%
Average annual growth 2019/20–2024/25
025 k50 k75 k100 k2019/202020/212021/222022/232023/242024/25

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k2019/202020/212021/222022/232023/242024/25

Dividends

from the accounts
2024/25

Dividends paid in the financial year: £20,500 (27% of the profit for the year).

Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Turnover———136,791202,489
Profit for the year———38,63374,793
Cash at bank and in hand———67,157143,413
Total assets49,25424,54828,46473,155150,836
Total liabilities7,8316,70210,39631,93154,977
Net assets / total equity41,2491,2661,28139,91494,207
Average number of employees11133
Dividends paid————20,500

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: GBSPP LIMITED

Company

GBSPP LIMITED is a private limited company registered with Companies House under company number 10385691. It was incorporated on 20 Sep 2016. Its status is active. The registered office is in Stanford-le-hope (SS17). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Turnover was £202,489. Profit for the year was £74,793. Net assets were £94,207, up 136% on the previous year. Cash at bank and in hand was £143,413. Total assets were £150,836 and total liabilities £54,977. The company had an average of 3 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 3 Oct 2027.